Dehydroepiandrosterone-mediated decrease in caloric intake by obese - Zucker rats is not due to changes in serum entrostatin-like immunoreactivity

Physiology and Behavior

Volumn 68, Issue 3, 2000, Pages 341-345

  Prasad, Anoop ^a   Richards, Robert J ^a   Svec, Frank ^a   Porter, Johnny R ^a,b   Prasad, Chandan ^a  

^a Obesity Research Program   (United States)

^b Obesity Research Program   (United States)

Author keywords

Appetite; Body weight; Dehydroepiandrosterone; Enterostatin; Fat intake

Indexed keywords

ENTROSTATIN; NEUROPEPTIDE; PRASTERONE; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; APPETITE; ARTICLE; BODY WEIGHT; CALORIC INTAKE; CONTROLLED STUDY; HORMONAL REGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN METABOLISM; RAT;

EID: 0033952389     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-9384(99)00185-7     Document Type: Article

References (47)

1. Deslypere J.P. Obesity and cancer. Metabolism. 44(Suppl 3):1995;24-27.
2. Kuller L.H. Eating fat or being fat and risk of cardiovascular disease and cancer among women. Ann Epidemiol. 4:1994;119-127.
3. Toeller M., Gries F.A., Dannehl K. Natural history of glucose intolerance in obesity. a ten year observation Int J Obes. 6(Suppl 1):1982;145-149.
4. Garn S.M., Clark D.C. Trends in fatness and the origin of obesity. Pediatrics. 57:1976;443-456.
5. Bobbioni-Harch E., Habicht F., Lehman T., James R.W., Rohner-Jeanrenaud F., Golay A. Energy expenditure and substrate oxidative patterns, after glucose, fat or mixes load in normal weight subjects. Eur J Clin Nutr. 51:1997;370-374.
6. Bray G.A. Hypothalamic and genetic obesity. an appraisal of the autonomic hypothesis and the endocrine hypothesis Int J Obes. 8(Suppl 1):1984;119-137.
7. Bray G.A. Peptides affect the intake of specific nutrients and the sympathetic nervous system. Am J Clin Nutr. 55(Suppl 1):1992;265S.
8. Bray G.A. The nutrient balance hypothesis. peptides, sympathetic activity, and food intake Ann NY Acad Sci. 676:1993;223-241.
9. Erlanson-Albertsson C. Enterostatin. the pancreatic procolipase activation peptide - a signal for regulation of fat intake Nutr Rev. 50:1992;307-310.
10. Leibowitz S.F., Weiss G.F., Walsh U.A., Viswanath D. Medial hypothalamic serotonin. role in circadian patterns of feeding and macronutrient selection Brain Res. 503:1989;132-140.
11. Prasad C., de la Houssaye A.J., Prasad A., Mizuma H. Augmentation of dietary fat preference by chronic, but not acute, hypercorticosteronemia. Life Sci. 56:1995;1361-1371.
12. Smith B.K., Berthoud H.R., York D.A., Bray G.A. Differential effects of baseline macronutrient preferences on macronutrient selection after galanin, NPY, and an overnight fast. Peptides. 18:1997;207-211.
13. Smith B.K., York D.A., Bray G.A. Chronic d-fenfluramine treatment reduces fat intake independent of macronutrient preference. Pharmacol Biochem Behav. 60:1998;105-114.
14. Wright B.E., Svec F., Porter J.R. Central effects of dehydroepiandrosterone in Zucker rats. Int J Obes Related Metab Disord. 19:1995;887-892.
15. Sorhede M., Mei J., Erlanson-Albertsson C. Enterostatin. a gut-brain peptide regulating fat intake in rat J Physiol (Paris). 87:1993;273-275.
16. Erlanson-Albertsson C. Pancreatic lipase, colipase and enterostatin - a lipolytic triad. Mackness M.I., Clerc M. Esterases, Lipases and Phospholipases. From Structure to Clinical Significance:1994;159-168 Plenum Press, New York.
17. Erlanson-Albertsson C., Mei J., Okada S., York D., Bray G.A. Pancreatic procolipase propeptide, enterostatin, specifically inhibits fat intake. Physiol Behav. 49:1991;1191-1194.
18. Okada S., York D.A., Bray G.A., Erlanson-Albertsson C. Enterostatin (Val- Pro-Asp-Pro-Arg), the activation peptide of procolipase, selectively reduces fat intake. Physiol Behav. 49:1991;1185-1189.
19. Shargill N.S., Tsujii S., Bray G.A., Erlanson-Albertsson C. Enterostatin suppresses food intake following injection into the third ventricle of rats. Brain Res. 544:1991;137-140.
20. Kumar B.A., Leibowitz S.F. Impact of acute corticosterone administration on feed and macronutrient self-selection patterns. Am J Physiol. 254:1988;R222-R228.
21. Bligh M.E., DeStefano M.B., Kramlik S.K., Douglass L.W., Dubuc P., Castonguay T.W. Adrenal modulation of the enhanced fat intake subsequent to fasting. Physiol Behav. 48:1990;373-381.
22. Castonguay T.W., Dallman M.F., Stern J.S. Some metabolic and behavioral effects of adrenalectomy on obese Zucker rats. Am J Physiol. 251:1986;R923-R933.
23. Castonguy T.W. Glucocorticoids as modulators in the control of feeding. Brain Res Bull. 27:1991;423-428.
24. Hampl R., Starka L. Dehydroepiandrosterone, "the youth hormone," in the light of recent findings. Casopis Lekaru Ceskych. 137:1998;8-12.
25. Reus V.I., Wolkowitz O.M., Frederick S. Antiglucocorticoid treatments in psychiatry. Psychoneuroendocrinology. 22(Suppl 1):1997;S121-S124.
26. Anonymous Early responses of female obese rats to dehydroepiandrosterone treatment. Nutr Rev. 49:1991;280-282.
27. Berdanier C.D., Parente J.A. Jr., McIntosh M.K. Is dehydroepiandrosterone an antiobesity agent? FASEB J. 7:1993;414-419.
28. Cleary M.P. The antiobesity effect of dehydroepiandrosterone in rats. Proc Soc Exp Biol Med. 196:1991;8-16.
29. Clore .N Dehydroepiandrosterone and body fat. Obes Res. 3(Suppl 4):1995;613S-6136.
30. Svec F., Abadie J., Browne E.S., Porter J.R. Dehydroepiandrosterone and macronutrient selection by obese Zucker rats (fa/fa). Appetite. 25:1995;143-154.
31. Imamura M., Porter J.R., Prasad C. Differential regional distribution of enterostatin, an appetite inhibiting peptide, in the brains of Zucker and Sprague-Dawley rats. Nutr Neurosci. 1:1999;449-453.
32. Mizuma H., Imamura M., Tiemann W.E., Prasad C. Biology of enterostatin. II. Development of enzyme-linked immunosorbentassay (ELISA) for enterostatin (Val Pro-Asp-Pro-Arg), the procolipase activation peptide. Biochem Biophys Res Commun. 215:1995;227-234.
33. Sorhede M., Erlanson-Albertsson C., Mei J., Nevalainen T., Aho A., Sundler F. Enterostatin in gut endocrine cells - immunocytochemical evidence. Peptides. 17:1996;609-614.
34. Sorhede M., Mulder H., Mei J., Sundler F., Erlanson-Albertsson C. Procolipase is produced in the rat stomach - a novel source of enterostatin. Biochim Biophys Acta. 1301:1996;207-212.
35. Okada S., York D.A., Bray G.A. Procolipase mRNA. tissue localization and effects of diet and adrenalectomy Biochem J. 292:1993;787-789.
36. Tagliaferro A.R., Ronan A.M., Payne J., Meeker L.D., Tse S. Increased lipolysis to beta-adrenergic stimulation after dehydroepiandrosterone treatment in rats. Am J Physiol. 268:1995;R1374-R1380.
37. Baulieu E-E, Robel P, Vatier O, Haug M, Goascogne C, Bourreau E. In: Fuxe K, Agnati LF, editors. Receptor-Receptor Interactions, a New Intermembrane Integrative Mechanism. Baingstoke: MacMillan, 1987. pp. 89-104.
38. Majewska M.D. Neurosteroids. endogenous bimodal modulators of the GABAA receptor. Mechanism of action and physiological significance Prog Neurobiol. 38:1992;379-395.
39. Frye C.A., Sturgis J.D. Neurosteroids affect spatial/reference, working, and long term memory of female rats. Neurobiol Learn Mem. 64:1995;83-96.
40. Melchior C.L., Ritzmann R.F. Neurosteroids block the memory-impairing effects of ethanol in mice. Pharmacol Biochem Behav. 53:1996;51-56.
41. Yoo A., Harris J., Dubrovsky B. Dose-response study of dehydroepiandrosterone sulfate on dentate gyrus long-term potentiation. Exp Neurol. 137:1996;151-156.
42. Melchior C.L., Ritzmann R.F. Dehydroepiandrosterone is an anxiolytic in mice on the plus maze. Pharmacol Biochem Behav. 47:1994;437-441.
43. Reddy D.S., Kulkarni S.K. Differential anxiolytic effects of neurosteroids in the mirrored chamber behavior test in mice. Brain Res. 752:1997;61-71.
44. Steffensen SC. Dehydroepiandrosterone sulfate suppresses hippocampal recurrent inhibition and synchronizes neuronal activity to theta rhythm. Hippocampus 188515:320-328.
45. Wolkowitz O.M., Reus V.I., Roberts E., Manfredi F., Chan T., Raum W.J., Ormiston S., Johnson R., Canick J., Brizendine L., Weingartner H. Dehydroepiandrosterone (DHEA) treatment of depression. Biol Psychiatry. 41:1997;311-318.
46. Friess E., Trachsel L., Guldner J., Schier T., Steiger A., Holsboer F. DHEA administration increases rapid eye movement sleep and EEG power in the sigma frequency range. Am J Physiol. 268:1995;E107-E113.
47. Li S., Garcia de Yebenes E., Pelletier G. Effects of dehydroepiandrosterone (DHEA) on GnRH gene expression in the rat brain as studied by in situ hybridization. Peptides. 16:1995;425-430.